Please login to the form below

Not currently logged in
Email:
Password:

Harren Jhoti and Will West join BIA board

UK biotech trade body welcomes CEOs of Astex Pharmaceuticals and CellCentric

The UK's BioIndustry Association (BIA) has appointed Harren Jhoti, CEO of Astex Pharmaceuticals, and Will West, CEO of CellCentric, to its board of directors.

They take over from Andrew Heath, managing director of Morvus, and Dominique Kleyn, CEO of London Genetics, who will stand down at the end of 2012.

The BIA, which represents the country's bioscience industry, also re-appointed Allan Marchington, partner at Apposite Capital, to the board.

All appointments will serve from January 1, 2013, for a term of two years.

Tim Edwards, BIA chairman, said: “As a result of these appointments, I believe our board continues to broaden its outlook and experience, and I look forward to working with them and the BIA team to ensure the UK remains a world-leading location for the life sciences.”

10th October 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics